REITs historically have generated real income and outperformed other assets in a high inflationary environment.
Strong demand for chips may persist in the coming years due to the increasing penetration of 5G smartphones, Internet of Things (IoT), and post-pandemic digital transformation that spurs demand for new generation data centers and cloud services.
Biotech’s significant drawdown and underperformance this year have created a long-term growth opportunity at a reasonable price.
While the broad US equity market posted its sixth straight month of gains in Q3, the tug of war between value and growth has intensified, evidenced by record high volatility of return differences between value and growth indices.1 Meanwhile, our economists believe that although inflation driven by supply chain disruptions and pent-up demand during the pandemic recovery might be peaking, rising rent and housing costs may keep inflation elevated next year.2 While the market historically has tended to be bumpier in Q4, inflationary pressure and some secular industry trends may persist regardless of short-term market sentiment. Therefore, we see three industry opportunities for the final quarter of 2021.
REITs: Pursue Income and Total Return in an Inflationary Environment With interest rates near pre-pandemic lows and actual inflation as well as inflation expectations elevated, US REIT funds’ ability to provide dividend income exceeding inflation has attracted investors this year. Because most leases are tied to inflation, income from leases and property values tend to increase when overall price levels rise. This supports REITs’ dividend growth and helps investors to pursue real income during inflationary periods. In all but three of the past 20 years, REITs' dividend increases have outpaced inflation as measured by the Consumer Price Index.3 Although the dividend yield of the US REITs industry has declined to around 3% as some REIT share prices increase, this income level is still much higher than inflation expectations and yields of investment-grade bonds.4 As the REITs sector continues to recover from the economic downturn, increases in lease payments likely will boost dividend distributions.
From a total return perspective, REITs also provide investors a powerful tool for inflation hedging. Rolling 12-month average of CPI inflation rate has increased for six straight months in August and now sits at 3%, well above the historical median. While inflation has shown signs of peaking recently, it’s likely to remain elevated in the coming months as the economic recovery continues. And when 12-month average CPI inflation has been in the top two quintiles, REITs have outperformed broad equities, US Treasury Inflation-Protected Securities (TIPS) and high yield bonds and been on par or slightly exceeded broad commodities, as shown in the chart below. This underscores REITs’ total return advantage over other assets in a high inflationary environment.
Source: Bloomberg Finance L.P., FactSet, between February 1, 1998 and July 31, 2021. Past performance is not a guarantee of future results. Index returns are unmanaged and do not reflect the deduction of any fees and expenses. Index returns reflect all items of income, gain and loss and the reinvestment of dividends and other income as applicable. Commodities = S&P GSCI Total Return Index. US TIPS = Bloomberg US Treasury Inflation-Linked Bond Index. HY Corp. = Bloomberg US High Yield Corporate Bond Index. US Equities = S&P 500 Index.
Although REIT mutual funds and ETFs have attracted more than $12 billion on a trailing 12-month basis, flows relative to the sector’s asset base are around the historical median of 6% and well below the average of 11% from 2010 to 2012 when the US economy recovered from the last recession.5 This may indicate investors are not overcrowded in terms of sector positioning.
Semiconductors: A Beneficiary of Surging 5G Adoption and World Digitalization The worldwide semiconductor market is projected to grow 25% to $551 billion in 2021, following 6.8% growth in 2020, according to World Semiconductor Trade Statistics.6 Strong demand for chips may persist in the coming years driven by increasing penetration of 5G smartphones, Internet of Things, and a post-pandemic digital transformation that spurs demand for data centers and cloud services.
5G smartphones have rapidly gained mobile phone market share, as shown in the chart below. With more mobile phone brands launching 5G-compatible models, the momentum is expected to continue. IDC forecasts that 5G smartphones’ share of global shipments will increase to 69% in 2025.7 As one of the most critical and high-value components of 5G smartphones, smartphone semiconductors are estimated to capture nearly two thirds of the revenue from 5G smartphones,8 one of the largest beneficiaries from the increasing penetration of 5G handsets.
Source: Counterpoint Research Market Monitor, as of March 31, 2021.
The Internet of Things (IoT) presents long-term and diverse growth opportunities for semiconductors in the 5G era — from smart home devices to industrial and automotive applications. Integrated circuits that process and store data and execute commands are the essential element of IoT, enabling fast and energy-efficient connections for machines and devices. The IoT may significantly boost semiconductor revenues by stimulating demand for microcontrollers, sensors, connectivity, and memory chips.
Another secular tailwind for the semiconductor industry is the pandemic’s acceleration of digital transformation. The increase in remote work and migration of digital assets to the cloud are two of the largest enterprise shifts that will most likely remain after the crisis.9 The strong demand for data center capacity in enterprise markets has spurred capital expenditure by hyperscale data center operators such as Amazon AWS, Microsoft, Google, and Oracle this year.10 The memory integrated circuit makers are the key beneficiary of this rapid growth, as the segment is the industry’s largest growth contributor.11
Biotech: A Secular Growth Opportunity with Attractive Valuations The biotech industry had a maximum drawdown of 32% since its peak in February this year.12 Even after rebounding 12% from its August trough, the industry still lags the healthcare sector and broader market by 23% and 25% year to date.13 Over the past 15 years, there were only two periods when the industry suffered a loss greater than 30% over a six month or longer period: 2015-2016 triggered by Hillary Clinton’s tweets about drug pricing and 2008-2009 during the global financial crisis.14 Both times biotech recovered from the downturn to stage a strong multi-year rally.
Historically, when the biotech industry has had more than a 10% drawdown, returns for the following years have most often been quite positive, as shown in the histogram chart below. The average return for the next 12 months after a 10% drawdown was 24%, with 81% of the time producing positive returns. Longer-term performance was even stronger, with 46% and 65% average cumulative returns for the following two and three years, respectively. Therefore, historical statistics suggest this year’s biotech selloff might create a great entry point for investors who are looking for long-term growth opportunities but can also stomach the sector’s high volatility.
Source: FactSet, from 3/31/2006 to 8/31/2021. Past performance is not a guarantee of future results. Index returns are unmanaged and do not reflect the deduction of any fees and expenses. Index returns reflect all items of income, gain and loss and the reinvestment of dividends and other income as applicable. Biotech is represented by the S&P Biotech Select Industry Index.
Biotech’s significant drawdown and underperformance this year have led to attractive valuations on a relative and absolute basis. The industry price-to-sales ratio is in the 67th percentile over the past 15 years, compared to the top percentile for the health care sector and the broader market, resulting in the most attractive relative biotech valuations in 15 years.15 These attractive valuations may also spark merger and acquisition (M&A) activities, as major drugmakers continue to search for new long-term growth opportunities and build their product pipeline. This is further supported by the industry’s strong balance sheet, as the debt to capital ratio has been low compared to historical levels.16
The SPDR® S&P Biotech Industry ETF (XBI) may help investors capture the secular growth in advanced medicine at a reasonable price. Given its small-cap tilt as a result of its modified equal-weighted approach, XBI also may benefit from a potential increase in M&A activities among small-cap biotech firms.
To learn more about emerging sector investing opportunities, visit our sectors webpage.
1FactSet, as of 10/1/2021. Value and Growth are represented by the S&P 500 Value and S&P 500 Growth indices. 2Weekly Economic Perspectives Quarterly Edition, September 27, 2021. 3Nareit, S&P Global Market Intelligence, as of December 2020. 4Bloomberg Finance L.P., as of 9/24/2021. 5Morningstar, as of 8/31/2021. 6Worldwide Semiconductor Market Outlook, World Semiconductor Trade Statistics, 8/16/2021. 7IDC, as of 3/10/2021. 8IDC forecasts $522B semiconductor market in 2021, May 2021. 9How COVID-19 has Pushed Companies Over the Technology Tipping Point and Transformed Business Forever, McKinsey, October 2021. 10AWS, Microsoft, Google Lead $38B Data Center Capex In Q1, CRN.com, June 2021. 11Worldwide Semiconductor Market Outlook, August 2021, World Semiconductor Trade Statistics. 12Bloomberg Finance L.P., as of 9/23/2021. 13Bloomberg Finance L.P., as of 9/23/2021. 14Bloomberg Finance L.P., as of 9/23/2021. 15FactSet, as of 9/16/2021. 16Biotech Industry Survey, CFRA, September 2021.
Bloomberg Barclays US High Yield Corporate Bond Index The index covers the universe of fixed rate, non-investment grade debt. Eurobonds and debt issues from countries designated as emerging markets (sovereign rating of Baa1/BBB+/BBB+ and below using the middle of Moody’s, S&P, and Fitch) are excluded, but Canadian and global bonds (SEC registered) of issuers in non-EMG countries are included. The index includes both corporate and non-corporate sectors.
Bloomberg Barclays US Treasury Inflation-Linked Bond Index The index measures the performance of the US Treasury Inflation Protected Securities (TIPS) market. Federal Reserve holdings of US TIPS are not index eligible and are excluded from the face amount outstanding of each bond in the index.
CPI Inflation Rate The change in the price index over a period of time
Price-to-Sales (P/S) Ratio A valuation ratio that compares a company’s stock price to its revenues.
Real Estate Investment Trust (REIT) Companies that own or finance income-producing real estate across a range of property sectors.
Semiconductor Materials which have a conductivity between conductors (generally metals) and nonconductors or insulators (such as most ceramics). Semiconductors can be pure elements, such as silicon or germanium, or compounds such as gallium arsenide or cadmium selenide. In a process called doping, small amounts of impurities are added to pure semiconductors causing large changes in the conductivity of the material.
S&P 500 Index The version of the popular benchmark for US large-cap equities that includes 500 companies from leading industries and captures about 80% coverage of available market capitalization in the US that reflects returns after reinvestment of dividends.
S&P GSCI Total Return Index The S&P GSCI Total Return Index in USD is widely recognized as the leading measure of general commodity price movements and inflation in the world economy. The index is calculated primarily on a world production-weighted basis comprised of the principal physical commodities futures contracts.
Important Risk Information This communication is not intended to be an investment recommendation or investment advice and should not be relied upon as such.
All information is from SSGA unless otherwise noted and has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information and it should not be relied on as such.
The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without SSGA’s express written consent.
The views expressed in this material are the views of SPDR ETFs and SSGA Funds Research Team through the period ended September 28, 2021 and are subject to change based on market and other conditions and do not necessarily represent the views of State Street Global Advisors or any of its affiliates. This document contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected.
Past performance is not a reliable indicator of future performance.
Investments in small-sized companies may involve greater risks than in those of larger, better known companies.
Targets are estimates based on certain assumptions and analysis made by SSGA. There is no guarantee that the estimates will be achieved.
Frequent trading of ETFs could significantly increase commissions and other costs such that they may offset any savings from low fees or costs.
Concentrated investments in a particular sector or industry tend to be more volatile than the overall market and increases risk that events negatively affecting such sectors or industries could reduce returns, potentially causing the value of the Fund’s shares to decrease.
Passively managed funds invest by sampling the Index, holding a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. This may cause the fund to experience tracking errors relative to performance of the Index.
Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions. Funds investing in a single sector may be subject to more volatility than funds investing in a diverse group of sectors.
Investing involves risk including the risk of loss of principal.
Real Estate Investment Trusts (REITS) investing may be subject to risks including, but not limited to, declines in the value of real estate, risks related to general economic conditions, changes in the value of the underlying property owned by the trust and defaults by borrowers.
Technology companies, including cyber security companies, can be significantly affected by obsolescence of existing technology, limited product lines, and competition for financial resources, qualified personnel, new market entrants or impairment of patent and intellectual property rights that can adversely affect profit margins.
The trademarks and service marks referenced herein are the property of their respective owners. Third party data providers make no warranties or representations of any kind relating to the accuracy, completeness or timeliness of the data and have no liability for damages of any kind relating to the use of such data.
ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.
Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.
Distributor: State Street Global Advisors Funds Distributors, LLC, member FINRA, SIPC, an indirect wholly owned subsidiary of State Street Corporation. References to State Street may include State Street Corporation and its affiliates. Certain State Street affiliates provide services and receive fees from the SPDR ETFs. ALPS Distributors, Inc., member FINRA, is the distributor for DIA, MDY and SPY, all unit investment trusts. ALPS Portfolio Solutions Distributor, Inc., member FINRA, is the distributor for Select Sector SPDRs. ALPS Distributors, Inc. and ALPS Portfolio Solutions Distributor, Inc. are not affiliated with State Street Global Advisors Funds Distributors, LLC.
THIS SITE IS INTENDED FOR QUALIFIED INVESTORS ONLY.
No Offer/Local Restrictions
Nothing contained in or on the Site should be construed as a solicitation of an offer to buy or offer, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction. SSGA Intermediary Business offers a number of products and services designed specifically for various categories of investors. Not all products will be available to all investors. The information provided on the Site is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation.
All persons and entities accessing the Site do so on their own initiative and are responsible for compliance with applicable local laws and regulations. The Site is not directed to any person in any jurisdiction where the publication or availability of the Site is prohibited, by reason of that person's nationality, residence or otherwise. Persons under these restrictions must not access the Site.
Information for Non-U.S. Investors:
The products and services described on this web site are intended to be made available only to persons in the United States or as otherwise qualified and permissible under local law. The information on this web site is only for such persons. Nothing on this web site shall be considered a solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction.
Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-866-787-2257, download a prospectus or summary prospectusnow, or talk to your financial advisor. Read it carefully before investing.
Not FDIC Insured * No Bank Guarantee * May Lose Value